IL143808A0 - Oral vaccine against diarrhea - Google Patents

Oral vaccine against diarrhea

Info

Publication number
IL143808A0
IL143808A0 IL14380899A IL14380899A IL143808A0 IL 143808 A0 IL143808 A0 IL 143808A0 IL 14380899 A IL14380899 A IL 14380899A IL 14380899 A IL14380899 A IL 14380899A IL 143808 A0 IL143808 A0 IL 143808A0
Authority
IL
Israel
Prior art keywords
vaccine against
oral vaccine
against diarrhea
diarrhea
oral
Prior art date
Application number
IL14380899A
Other languages
English (en)
Original Assignee
Sbl Vaccin Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbl Vaccin Ab filed Critical Sbl Vaccin Ab
Publication of IL143808A0 publication Critical patent/IL143808A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55544Bacterial toxins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
IL14380899A 1998-12-18 1999-12-09 Oral vaccine against diarrhea IL143808A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804415A SE515285C2 (sv) 1998-12-18 1998-12-18 Oralt vaccin mot diarré
PCT/SE1999/002306 WO2000037106A1 (en) 1998-12-18 1999-12-09 Oral vaccine against diarrhea

Publications (1)

Publication Number Publication Date
IL143808A0 true IL143808A0 (en) 2002-04-21

Family

ID=20413742

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14380899A IL143808A0 (en) 1998-12-18 1999-12-09 Oral vaccine against diarrhea

Country Status (25)

Country Link
EP (2) EP1140159A1 (cs)
JP (1) JP2002532562A (cs)
KR (1) KR20010101233A (cs)
CN (1) CN1330552A (cs)
AP (1) AP1426A (cs)
AU (1) AU778223B2 (cs)
BR (1) BR9916278A (cs)
CA (1) CA2352309A1 (cs)
CZ (1) CZ20011947A3 (cs)
EE (1) EE200100309A (cs)
HR (1) HRP20010433A2 (cs)
HU (1) HUP0104552A3 (cs)
ID (1) ID29857A (cs)
IL (1) IL143808A0 (cs)
IS (1) IS5967A (cs)
MX (1) MXPA01006200A (cs)
NO (1) NO20012889D0 (cs)
NZ (1) NZ527559A (cs)
OA (1) OA11729A (cs)
PL (1) PL198438B1 (cs)
SE (1) SE515285C2 (cs)
TR (1) TR200101542T2 (cs)
WO (1) WO2000037106A1 (cs)
YU (1) YU41701A (cs)
ZA (1) ZA200104362B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2437899C (en) * 2001-02-13 2012-05-15 Gregory M. Glenn Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
EP1543836A1 (en) * 2003-12-17 2005-06-22 Berna Biotech AG Recombinant Vibrio cholerae strain and vaccine comprising said strain
WO2008133926A1 (en) * 2007-04-24 2008-11-06 Celldex Therapeutics, Inc: V. cholerae hyperexpressing recombinant cholera toxin b subunit showing dual immunogenicity
WO2013037397A1 (en) * 2011-09-12 2013-03-21 Scandinavian Biopharma Holding Ab Vaccine for protection against etec induced diarrhea comprising dmlt.
PL2750701T3 (pl) 2011-09-12 2016-03-31 Scandinavian Biopharma Holding Ab Sposób zwiększania prezentacji antygenu ETEC CS6 na powierzchni komórki i jego produkty, które można otrzymać
RU2753410C2 (ru) * 2020-01-14 2021-08-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" Способ получения анатоксин-вакцины против эшерихиоза животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100556D0 (sv) * 1991-02-26 1991-02-26 Holmgren Jan Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans

Also Published As

Publication number Publication date
AU3088900A (en) 2000-07-12
BR9916278A (pt) 2001-09-04
AP1426A (en) 2005-06-06
SE9804415D0 (sv) 1998-12-18
MXPA01006200A (es) 2002-04-17
YU41701A (sh) 2005-07-19
NO20012889L (no) 2001-06-12
CN1330552A (zh) 2002-01-09
CZ20011947A3 (cs) 2001-12-12
EP1444987A2 (en) 2004-08-11
NO20012889D0 (no) 2001-06-12
SE515285C2 (sv) 2001-07-09
PL198438B1 (pl) 2008-06-30
ID29857A (id) 2001-10-18
NZ527559A (en) 2005-01-28
EP1444987A3 (en) 2005-12-21
CA2352309A1 (en) 2000-06-29
KR20010101233A (ko) 2001-11-14
IS5967A (is) 2001-06-13
TR200101542T2 (tr) 2001-10-22
WO2000037106A1 (en) 2000-06-29
EP1140159A1 (en) 2001-10-10
HRP20010433A2 (en) 2002-06-30
HUP0104552A2 (hu) 2002-04-29
HUP0104552A3 (en) 2002-08-28
JP2002532562A (ja) 2002-10-02
ZA200104362B (en) 2002-01-14
OA11729A (en) 2005-05-12
PL348257A1 (en) 2002-05-20
SE9804415L (sv) 2000-06-19
AU778223B2 (en) 2004-11-25
EE200100309A (et) 2002-08-15

Similar Documents

Publication Publication Date Title
GB9806456D0 (en) Vaccine composition
IL140094A0 (en) Vaccine
EP1020193A4 (en) ORAL PREPARATION
EP1072253A4 (en) PREPARATIONS TO BE ORALED
HUP0105392A3 (en) Enhanced vaccines
PL338922A1 (en) Oral compositions
GB0027072D0 (en) Vaccine
GB9822714D0 (en) Vaccines
PL348257A1 (en) Oral vaccine against diarrhea
GB9801870D0 (en) Vaccine composition
GB9817650D0 (en) Oral formulation
GB9823835D0 (en) Component for vaccine
GB9718616D0 (en) Oral vaccine
HK1042041A (en) Oral vaccine against diarrhea
GB9807805D0 (en) Vaccine
GB9820956D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9822703D0 (en) Vaccine
GB9807933D0 (en) Vaccine
GB9822712D0 (en) Vaccine
GB9822709D0 (en) Vaccine
GB9812773D0 (en) Vaccine
GB9812228D0 (en) Vaccine
GB9811954D0 (en) Vaccine
GB9802543D0 (en) Vaccine

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees